SANGAMO THERAPEUTICS INC
SGMO
SGMO was delisted on the 4th of May, 2026.
134 hedge funds and large institutions have $61.3M invested in SANGAMO THERAPEUTICS INC in 2023 Q3 according to their latest regulatory filings, with 9 funds opening new positions, 33 increasing their positions, 49 reducing their positions, and 26 closing their positions.
12% more call options, than puts
Call options by funds: $91K | Put options by funds: $81K
3.95% less ownership
Funds ownership: 61.65% → 57.7% (-4%)
12% less funds holding
Funds holding: 152 → 134 (-18)
33% less repeat investments, than reductions
Existing positions increased: 33 | Existing positions reduced: 49
55% less capital invested
Capital invested by funds: $137M → $61.3M (-$76.1M)
65% less first-time investments, than exits
New positions opened: 9 | Existing positions closed: 26
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WA
Wasatch Advisors
Salt Lake City,
Utah
|
+$1M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$901K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$695K |
| 4 |
Goldman Sachs
New York
|
+$540K |
| 5 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
+$316K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GC
Globeflex Capital
San Diego,
California
|
-$907K |
| 2 |
Jane Street
New York
|
-$864K |
| 3 |
Dimensional Fund Advisors
Austin,
Texas
|
-$790K |
| 4 |
Renaissance Technologies
New York
|
-$751K |
| 5 |
HF
HRT Financial
New York
|
-$739K |
SGMO Hedge Fund Activity: Q3 2023 in Review
134 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in SANGAMO THERAPEUTICS INC (SGMO) for Q3 2023, worth a combined $61.3M — down 55% from $137M a quarter earlier.
Sellers outnumbered buyers: 26 funds closed out of SGMO and 9 opened new positions — a net loss of 17 holders — while 49 trimmed existing stakes and 33 added.
The largest buyer was Wasatch Advisors, adding an estimated $1M. The largest seller was Globeflex Capital, exiting entirely with an estimated $907K sold.
- 134 institutional investors held SANGAMO THERAPEUTICS INC (SGMO) as of Q3 2023, down from 152 in Q2 2023.
- Funds reported $61.3M of SANGAMO THERAPEUTICS INC stock for Q3 2023, down 55% quarter-over-quarter.
- 9 funds opened new SANGAMO THERAPEUTICS INC positions in Q3 2023 and 26 closed out, a net change of -17 holders.
- The largest SANGAMO THERAPEUTICS INC buyer in Q3 2023 was Wasatch Advisors, an estimated $1M added.
- The largest SANGAMO THERAPEUTICS INC seller in Q3 2023 was Globeflex Capital, an estimated $907K sold.
Based on aggregated 13F filings for Q3 2023.